Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses (2021)

First Author: Chandran A

Attributed to: A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.30.21254540

Publication URI: http://dx.doi.org/10.1101/2021.03.30.21254540

Type: Preprint